entertainment -WSS

entertainment

author：comprehensive 2025-10-01 23:43:27 - browse：7328

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Biden administration begins canceling student loan debt for 804,000 borrowers

WSS

First transplant of an entire human eye performed

Carbon Health diabetes program, a test of data

A letter from the executive editor: STAT UnitedHealth investigation

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Timeline: How the deadly wildfires took over Maui day by day

Type 2 diabetes prevention programs work at large scale: study

leisure time

entertainment

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Mark Cuban is blaming the wrong people for high drug costs

Moonlake's readout produced a cash windfall. Risks remain

Type 2 diabetes prevention programs work at large scale: study

Trump demands the U.S. pay no more for drugs than other countries … again

What health policies could hitch a ride on a spending bill?

State Dept. review finds Biden bears some blame for Afghanistan failures

After Optum profits sink, UnitedHealth makes changes

After affirmative action ruling, medical educators look to 'holistic review'

What is STAT's opinion section for?

hotspot

Dozens dead from Maui wildfires: What we know about the victims

A letter from the executive editor: STAT UnitedHealth investigation

Type 2 diabetes prevention programs work at large scale: study

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Indictment alleges Trump's ex

What is STAT's opinion section for?

leisure time

focus

Wikipedia

entertainment